Polarityte Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.0666
- Today's High:
- $0.0699
- Open Price:
- $0.0666
- 52W Low:
- $0.06
- 52W High:
- $1.09
- Prev. Close:
- $0.0666
- Volume:
- 7225
Company Statistics
- Market Cap.:
- $1.78 million
- Book Value:
- 1.742
- Revenue TTM:
- $73000
- Operating Margin TTM:
- -29868.49%
- Gross Profit TTM:
- $198000
- Profit Margin:
- 0%
- Return on Assets TTM:
- -56.67%
- Return on Equity TTM:
- -54.97%
Company Profile
Polarityte Inc had its IPO on 1999-08-13 under the ticker symbol PTE.
The company operates in the Healthcare sector and Biotechnology & Medical Research industry. Polarityte Inc has a staff strength of 42 employees.
Stock update
Shares of Polarityte Inc opened at $0.07 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.07 - $0.07, and closed at $0.07.
This is a 0% increase from the previous day's closing price.
A total volume of 7,225 shares were traded at the close of the day’s session.
In the last one week, shares of Polarityte Inc have slipped by -6.46%.
Polarityte Inc's Key Ratios
Polarityte Inc has a market cap of $1.78 million, indicating a price to book ratio of 0.2948 and a price to sales ratio of 2.7772.
In the last 12-months Polarityte Inc’s revenue was $73000 with a gross profit of $198000 and an EBITDA of $-20604000. The EBITDA ratio measures Polarityte Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Polarityte Inc’s operating margin was -29868.49% while its return on assets stood at -56.67% with a return of equity of -54.97%.
In Q1, Polarityte Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 100%.
Polarityte Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.58 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Polarityte Inc’s profitability.
Polarityte Inc stock is trading at a EV to sales ratio of 0.0643 and a EV to EBITDA ratio of 0.6399. Its price to sales ratio in the trailing 12-months stood at 2.7772.
Polarityte Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $18.05 million
- Total Liabilities
- $2.17 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Polarityte Inc ended 2024 with $18.05 million in total assets and $0 in total liabilities. Its intangible assets were valued at $18.05 million while shareholder equity stood at $12.42 million.
Polarityte Inc ended 2024 with $0 in deferred long-term liabilities, $2.17 million in other current liabilities, 7000.00 in common stock, $-520474000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $6.39 million and cash and short-term investments were $6.39 million. The company’s total short-term debt was $458,000 while long-term debt stood at $0.
Polarityte Inc’s total current assets stands at $8.93 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $446000.00 compared to accounts payable of $244000.00 and inventory worth $-446000.00.
In 2024, Polarityte Inc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Polarityte Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.07
- 52-Week High
- $1.09
- 52-Week Low
- $0.06
- Analyst Target Price
- $0.8
Polarityte Inc stock is currently trading at $0.07 per share. It touched a 52-week high of $1.09 and a 52-week low of $1.09. Analysts tracking the stock have a 12-month average target price of $0.8.
Its 50-day moving average was $0.1 and 200-day moving average was $0.5 The short ratio stood at 3.19 indicating a short percent outstanding of 0%.
Around 342.7% of the company’s stock are held by insiders while 938.5% are held by institutions.
Frequently Asked Questions About Polarityte Inc
Similar Industry Stocks (Biotechnology & Medical Research)
Most Active
Top Gainers
Top Losers
About
PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.